Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

CARLOS BUESA-ARJOL

CEO

ORYZON

Dr Buesa (BSc Biol Sc.) got his PhD in Mol. Biology from the Univ. of Barcelona, Spain. He was a EU post-doctoral fellow in the Faculty of Medicine at the Univ. of Ghent in Belgium and later Senior Investigator at the Flemish Institute of Biotechnology (VIB). He has also taken the executive PADE programme at IESE Business School and several other additional programs in finances. In 2000, he founded Oryzon, and since inception, he has been CEO and Chairman. Under his leadership the company has got +65M € in several equity funding rounds +70 M € in non dilutive funds. After a transforming partnering deal with Roche in 2014, Dr Buesa leaded Oryzon to become a public company in 2015 in the Madrid Main Stock exchange. In 1Q2017 he led a successful 18.2M€ Pipes ($20m) offering that included institutional investors specialized in healthcare and life sciences from the US, Spain and rest of Europe, In 2018 he led an additional 13M€ Pipe further reinforcing and diversifying the shareholder base

This speaker's sessions:

  • ORYZON
  • Monday, February 11
  • 2:45 PM - 3:00 PM
Back